(0.71%) 5 053.97 points
(0.67%) 38 156 points
(1.21%) 15 795 points
(-0.14%) $78.89
(5.33%) $2.04
(0.21%) $2 315.80
(0.61%) $26.91
(1.05%) $964.95
(-0.01%) $0.933
(-0.25%) $11.00
(0.01%) $0.799
(-1.33%) $92.02
4 days till quarter result
(bmo 2024-05-06)
Expected move: +/- 6.61%
@ $43.60
Išleistas: 14 vas. 2024 @ 22:55
Grąža: -34.01%
Ankstesnis signalas: vas. 14 - 19:37
Ankstesnis signalas:
Grąža: 0.58 %
Live Chart Being Loaded With Signals
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery...
Stats | |
---|---|
Šios dienos apimtis | 345 878 |
Vidutinė apimtis | 790 262 |
Rinkos kapitalizacija | 2.25B |
EPS | $0 ( 2024-04-25 ) |
Kita pelno data | ( $0.550 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 34.25 |
ATR14 | $0.0260 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | De Witte Jan | Buy | 41 414 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Sell | 205 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Buy | 95 664 | Non- Qualified Stock Option (right to buy) |
2024-03-11 | De Witte Jan | Buy | 205 | Common Stock |
2024-03-11 | De Witte Jan | Sell | 205 | Common Stock |
INSIDER POWER |
---|
80.45 |
Last 97 transactions |
Buy: 599 911 | Sell: 62 631 |
Tūris Koreliacija
Integra Lifesciences Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
JCOM | 0.914 |
EVOP | 0.903 |
ESGR | 0.893 |
PPH | 0.889 |
SDG | 0.888 |
HSIC | 0.885 |
KLAC | 0.884 |
INCY | 0.88 |
ISHG | 0.878 |
EM | 0.878 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
PLMR | -0.914 |
FTOC | -0.913 |
FTOCU | -0.913 |
FEYE | -0.9 |
HOLUU | -0.894 |
AYLA | -0.891 |
NRBO | -0.887 |
IMRX | -0.875 |
HHGCU | -0.874 |
TFFP | -0.872 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Integra Lifesciences Koreliacija - Valiuta/Žaliavos
Integra Lifesciences Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $1.54B |
Bruto pelnas: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2023 |
Pajamos: | $1.54B |
Bruto pelnas: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2022 |
Pajamos: | $1.56B |
Bruto pelnas: | $970.31M (62.29 %) |
EPS: | $2.18 |
FY | 2021 |
Pajamos: | $1.54B |
Bruto pelnas: | $944.64M (61.24 %) |
EPS: | $1.996 |
Financial Reports:
No articles found.
Integra Lifesciences
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.